$RLFTF Uncle Gee DD (copy) Post on inhalers ..
Post# of 653
.. the trial ending in March 2022 is an 80 patient study with a PREVENTATIVE inhaler. Trial: NCT04536350
The US trial of 288 patients estimated to complete Nov 31, 2020 is the TREATMENT inhaler. Trial: NCT04360096
The US trial of 288 patients is the horse we're all betting on. According to Dr. Javitt: “We expect that half the people we enroll in our inhaled study are going to be people who are outpatients.”
Disclaimer: I am not a professional advisor. Seek professional advice before investing or trading. I take risky positions and do not advise anyone to follow my opinions or actions.